postmenopausal vaginal atrophy


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.
Related to postmenopausal vaginal atrophy: Urogenital Atrophy

postmenopausal vaginal atrophy

Drying and shrinking of the vaginal tissues, related to the hormonal changes associated with menopause. Menopausal women who continue to engage in sexual intercourse during and following menopause have less vaginal atrophy than do those women who become sexually inactive. See: hormone replacement therapy
See also: atrophy
References in periodicals archive ?
List of Figures Figure 1: 7MM, Prevalent Cases of Postmenopausal Vaginal Atrophy, N, Select Years, 2012-2022 17 Figure 2: 7MM, Prevalent Cases of Postmenopausal Vaginal Atrophy, By Age, N, 2012 19 Figure 3: 7MM, Prevalent Cases of Postmenopausal Vaginal Atrophy, By Severity, N (%), 2012 20
To order this report: General_Medicine_and_Specialty_Medicine Industry : EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Postmenopausal Vaginal Atrophy Therapeutics market.
Analysis of key recent licensing and partnership agreements in Postmenopausal Vaginal Atrophy Therapeutics market
Develop business strategies by understanding the trends shaping and driving the global Postmenopausal Vaginal Atrophy Therapeutics market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Postmenopausal Vaginal Atrophy Therapeutics market in future.
What's the next big thing in the global Postmenopausal Vaginal Atrophy Therapeutics market landscape?
17 Drivers and Barriers for the Postmenopausal Vaginal Atrophy Therapeutics Market 28
1 Drivers for the Postmenopausal Vaginal Atrophy Therapeutics Market 28
2 Barriers to the Postmenopausal Vaginal Atrophy Therapeutics Market 28
3 Product Profiles for the Major Marketed Products in the Postmenopausal Vaginal Atrophy Therapeutics Market 31
3 Postmenopausal Vaginal Atrophy Therapeutics Pipeline - Pipeline by Phase of Development 36